Goud Alladi, C.; Etain, B.; Bellivier, F.; Marie-Claire, C.
DNA Methylation as a Biomarker of Treatment Response Variability in Serious Mental Illnesses: A Systematic Review Focused on Bipolar Disorder, Schizophrenia, and Major Depressive Disorder. Int. J. Mol. Sci. 2018, 19, 3026.
https://doi.org/10.3390/ijms19103026
AMA Style
Goud Alladi C, Etain B, Bellivier F, Marie-Claire C.
DNA Methylation as a Biomarker of Treatment Response Variability in Serious Mental Illnesses: A Systematic Review Focused on Bipolar Disorder, Schizophrenia, and Major Depressive Disorder. International Journal of Molecular Sciences. 2018; 19(10):3026.
https://doi.org/10.3390/ijms19103026
Chicago/Turabian Style
Goud Alladi, Charanraj, Bruno Etain, Frank Bellivier, and Cynthia Marie-Claire.
2018. "DNA Methylation as a Biomarker of Treatment Response Variability in Serious Mental Illnesses: A Systematic Review Focused on Bipolar Disorder, Schizophrenia, and Major Depressive Disorder" International Journal of Molecular Sciences 19, no. 10: 3026.
https://doi.org/10.3390/ijms19103026
APA Style
Goud Alladi, C., Etain, B., Bellivier, F., & Marie-Claire, C.
(2018). DNA Methylation as a Biomarker of Treatment Response Variability in Serious Mental Illnesses: A Systematic Review Focused on Bipolar Disorder, Schizophrenia, and Major Depressive Disorder. International Journal of Molecular Sciences, 19(10), 3026.
https://doi.org/10.3390/ijms19103026